Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Long-lived assets by Year
Long-lived assets — Outside the United States (Ex-U.S. total, $M) ($M)
Vertex Pharmaceuticals Long-lived assets: $195M in FY2025, up 1.2% from a year earlier. That is the highest of the 14 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Segment & Geographic Information Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-lived assets — Outside the United States (Ex-U.S. total, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 195 | +1.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 192 | +106.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 93.2 | +3.2% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 90.3 | +18.3% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 76.3 | -0.1% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 76.4 | +18.1% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 64.7 | +90.9% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 33.9 | -6.6% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 36.3 | +10.7% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 32.8 | -9.6% | Form 10-K (filed 2018-02-15) ↗ |
| FY2015 | Dec 31, 2015 | 36.3 | -6.4% | Form 10-K (filed 2017-02-23) ↗ |
| FY2014 | Dec 31, 2014 | 38.8 | -1.3% | Form 10-K (filed 2015-02-13) ↗ |
| FY2013 | Dec 31, 2013 | 39.3 | +17.3% | Form 10-K (filed 2014-02-11) ↗ |
| FY2012 | Dec 31, 2012 | 33.5 | – | Form 10-K (filed 2014-02-11) ↗ |
Breakdown
What makes up long-lived assets
Cite this data
StockData. (2026). Vertex Pharmaceuticals Long-lived assets ($M), annual FY2012–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/geo-lla-non-us
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.